Your browser doesn't support javascript.
loading
Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival.
Morales, Leah; Simpson, Danny; Ferguson, Robert; Cadley, John; Esteva, Eduardo; Monson, Kelsey; Chat, Vylyny; Martinez, Carlos; Weber, Jefrey; Osman, Iman; Kirchhof, Tomas.
Afiliação
  • Morales L; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.
  • Simpson D; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA.
  • Ferguson R; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA.
  • Cadley J; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.
  • Esteva E; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA.
  • Monson K; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA.
  • Chat V; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.
  • Martinez C; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA.
  • Weber J; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA.
  • Osman I; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.
  • Kirchhof T; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA.
J Transl Med ; 21(1): 234, 2023 Mar 31.
Article em En | MEDLINE | ID: mdl-37004035

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article